| Title |
TCL1A in naive B cells as a therapeutic target for type 1 diabetes |
| Description |
In this study, we collected peripheral blood mononuclear cells from patients newly diagnosed with T1D and the patients' parents for single-cell RNA sequencing, and performed bulk RNA seq on Ramos cells treated with the AKT2 inhibitor CCT128930 to further investigate the disease pathogenesis of T1D. |
| Organism |
Homo sapiens |
| Data Type |
Expression Profiling |
| Data Accessibility |
Controlled-access |
| BioProject |
PRJCA034718 |
| Release Date |
2025-02-18 |
| Submitter |
Yiming Zhou (zhouym35@mail.sysu.edu.cn) |
| Organization |
The First Affiliated Hospital, Sun Yat-sen University |
| Submission Date |
2025-01-16 |